4.7 Article

A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study

期刊

JOURNAL OF CLINICAL MEDICINE
卷 10, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/jcm10081584

关键词

cardiometabolic profile; cardiovascular risk; population studies

资金

  1. Municipal Office in Bialystok [W/UB/DSP/1640/UMBIALYSTOK/2017]
  2. Medical University of Bialystok [SUB/1/00/19/001/1201]

向作者/读者索取更多资源

The study found that participants in moderate and high cardiovascular risk classes had similar unfavorable cardiometabolic profiles and lifetime cardiovascular risk, suggesting the need for more aggressive treatment management in the moderate cardiovascular risk population. Therefore, new prospective population studies are necessary to establish different cardiovascular risk profiles in a changing society.
Background: Cardiovascular disease (CVD) is a major, worldwide problem that remains the dominant cause of premature mortality in the world, and increasing rates of dysglycaemia are a major contributor to its development. The aim of this study was to investigate the cardiometabolic profile among patients in particular cardiovascular risk classes, and to estimate their long term CV risk. Methods: A total of 931 individuals aged 20-79 were included. The study population was divided into CV risk classes according to the latest European Society of Cardiology recommendations. Results: Most of the analyzed anthropometric, body composition and laboratory parameters did not differ between the moderate and high CV risk participants. Interestingly, estimating the lifetime risk of myocardial infarction, stroke or CV death, using the LIFEtime-perspective model for individualizing CardioVascular Disease prevention strategies in apparently healthy people, yielded similar results in moderate and high CV risk classes. Conclusion: The participants who belonged to moderate and high CV risk classes had very similar unfavorable cardiometabolic profiles, which may result in similar lifetime CV risk. This may imply the need for more aggressive pharmacological and non-pharmacological management of CV risk factors in the moderate CV risk population, who are often unaware of their situation. New prospective population studies are necessary to establish the true cardiovascular risk profiles in a changing society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据